Some studies have reported that Nrf2 is frequently mutated in human cancer cells, leading to an increase in the expression of the corresponding protective genes and thereby giving these cells a growth advantage and anti-apoptotic ability (44). This evidence concerns the gene NFE2L2 and cancer.